MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disorder which is characterised by progressive accumulation of amyloid-beta (Aβ) peptides, forming senile plaques in the brain, and neurofibrillary tangles of hyperphosphorylated tau, followed by progressive neuronal and synaptic loss.